T G4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease relapse in patients with surgically resected HPV-negative head and neck squamous ...

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

On Thursday, BMS revealed that a phase 3 trial of Opdualag as an adjuvant treatment for patients with completely resected stage III and stage IV melanoma did not achieve its primary endpoint.

The appraisal committee has prepared final draft guidance (FDG) on pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907] and submitted it to NICE. The FDG has been sent ...